Lolu hlelo lokusebenza lulinganisela ingozi yakho evamile yomdlavuza, kanye nobungozi bezinhlobo ezingu-38 zomdlavuza ohlukene, ngokusekelwe ezicini ezinobungozi ezicishe zibe ngu-650 ezichazwe ezincwadini zesayensi. Imiphumela ikhonjiswa engcupheni yokuphila konke kanye nezikhathi zesikhathi zeminyaka engu-10, 20- kanye nengama-30, kanye nobungozi bokushona ngenxa yomdlavuza okukhulunywa ngawo. Ukuhlukaniswa iziqephu ezinhlotsheni ezincane ze-anatomical noma ze-pathological kunikezwa uma kungenzeka. Izinkomba ezinemininingwane zinikeziwe ngomthelela wesici sobungozi ngasinye.
Ukwengeza, amamodeli omdlavuza ashicilelwe futhi aqinisekisiwe afakiwe kuhlelo lokusebenza, ahlinzeka ngemininingwane eyengeziwe kubasebenzisi abanentshisekelo.
Lolu hlelo lokusebenza lunophawu lokuhambisana ne-CE njengethuluzi lezokwelapha elinobungozi obuncane. Kanjalo, silandele izinqubo zokuhlola ukuhambisana kwe-Class I njengoba kuchazwe ku-Annex VII Module A, EC Declaration of Conformity. Njengoba ithathwa njengethuluzi lezokwelapha elibeka engcupheni encane ezigulini nakubathengi, iwela ngaphansi kwemithetho ye-FDA yokuphoqelela ukusetshenziswa kwayo. Ukuze uthole ulwazi olwengeziwe, sicela uvakashele isigaba esifanele iwebhusayithi esemthethweni ye-FDA: https://www.fda.gov/medical-devices/mobile-medical-applications/examples-mobile-apps-which-fda-will-exercise-enforcement- ukuqonda
Ukuze usebenzise lolu hlelo lokusebenza, dala i-akhawunti bese ufaka imininingwane eceliwe kumathebhu ahlukene ngokunembe nangokuphelele ngangokunokwenzeka. Lonke ulwazi oluceliwe luyoba nomthelela engcupheni yakho yokuba okungenani nohlobo olulodwa lomdlavuza, ngakho uma ulwazi olufakayo luphelele futhi lunembe kakhudlwana, imiphumela ithembeke kakhulu. Iminyaka yobudala, ubulili nesizinda sobuhlanga kubalulekile, lonke olunye ulwazi luyinketho. Imiphumela izovela ngemva kokuqeda ithebhu yokugcina futhi ingabuye ivakashelwe kabusha ngokuthepha igama lakho. Ungaphinda uhlele ulwazi oluthumele ukuze ubone ukuthi lokhu kuyithinta kanjani imiphumela yakho.
Amathuba okuphila konke okuba nomdlavuza asekelwe kudatha yase-USA evela ku-National Cancer Institute's (NCI's) Surveillance, Epidemiology, kanye ne-End Results (SEER), eqoqwe kusukela ngo-1973 nayiCenters for Disease Control and Prevention's (CDC's) Uhlelo Lukazwelonke Lomdlavuza. Registries (NPCR), eqoqwe kusukela ngo-1995. Lezi zibalo zashintshwa yizilinganiso zezingozi ezitholakala ezincwadini ezishicilelwe ontanga. Kufakwe izinto engcuphe kuphela ezinengcuphe elinganisekayo. Izici zobungozi ezidinga ukuhlolwa okuyinkimbinkimbi okungatholakali kudokotela ojwayelekile azifakwanga. Ukuhlaziywa kwe-meta kwanikezwa okuncanyelwayo lapho kutholakala.
ISICELO: Lolu hlelo lokusebenza lufundisa ngokuphelele futhi lonke ulwazi oluqukethwe lapha alukwazi futhi akufanele luthathe indawo yokuhlolwa ngudokotela. Ukuhlola okwethulwayo kumelela imizamo yethu engcono kakhulu yokuhlola ubungozi bomdlavuza. Kodwa-ke, njengoba impikiswano ebalulekile kanye nemiphumela yocwaningo ehluke kakhulu ingaqhubeka mayelana nomthelela ngisho nokuguquguquka okukodwa kubantu abakhethwe ngokuqinile, lokhu kusekelwe enanini elikhulu lokuqagela, okungeziwe kanye nezilinganiso. Njengoba kungezona zonke izifundo ezihlanganisa ukuhlaziywa kwe-multivariate kanye nomphumela wezinye izici zobungozi kuma-cancer athile mkhulu kakhulu umphumela wabo awukwazi ukuqedwa emathubeni ayisisekelo, ukuchema kokulinganisa ubungozi kungenzeka. Ngaphezu kwalokho, kunenqubekelaphambili eqhubekayo emibhalweni yesayensi. Ngakho-ke noma yiziphi izibalo kufanele zithathwe njengezinkomba, kodwa hhayi ezinembayo.
Noma yiluphi ulwazi olufaka kulolu hlelo lokusebenza luzogcinwa kuphela kudivayisi yakho futhi alusoze lwathunyelwa kithi noma kunoma iyiphi enye inhlangano, nganoma yisiphi isizathu.
Lonke ucwaningo nokwesekwa kwezokwelapha kwalolu hlelo lwenziwa nguDkt. Philippe Westerlinck, udokotela we-radiation oncologist kanye nosihlalo we-clinical eSibhedlela sase-University of Liège, egxile kakhulu kumdlavuza wamathumbu, wamaphaphu nowebele.
Kubuyekezwe ngo-
Nov 11, 2023